AliveDx Suisse S.A. is pleased to announce the signing of a strategic distribution agreement with Reacting Sarl. Under this agreement, Reacting Sarl is authorized to distribute AliveDx’s MosaiQ® and LumiQ® solutions across Morocco.
This partnership represents a further step in AliveDx’s expansion across North Africa and underscores its commitment to working with strong local partners to deliver innovative and high-value diagnostic technologies. Through this collaboration, AliveDx and Reacting Sarl aim to enhance access to advanced diagnostics, supporting clinicians in shortening time to diagnosis and improving patient outcomes.
Transforming Diagnostics with MosaiQ® & LumiQ®
The MosaiQ® and LumiQ® platforms are designed to simplify laboratory workflows and improve operational efficiency through fully automated, multiplex microarray assay technology. These solutions enable laboratories to deliver faster, more cost-effective, and high-quality diagnostic results, benefiting healthcare providers and patients alike.
“We are pleased to welcome Reacting Sarl as a distribution partner in Morocco. This agreement reflects AliveDx’s strategy of collaborating with experienced and reputable partners to bring cutting-edge diagnostic solutions to healthcare systems across the region,” said Manuel O. Méndez, CEO of AliveDx.
“Morocco is an important market for AliveDx in North Africa. Partnering with a strong leading partner like Reacting Sarl enables us to work closely with a strong knowledgeable local organization that understands the market and its needs. We look forward to building a strong collaboration that delivers clinical and economic value to laboratories and clinicians,” said Khaled Hamed, Head of Global Emerging Markets, AliveDx.
About Reacting Sarl
Reacting is a private Moroccan company specializing in the distribution of laboratory products in Morocco and North Africa. In addition to its traditional in vitro diagnostic activities, Reacting is now diversifying and extending its reach to the medical and surgical sector.
“We are proud to partner with AliveDx and to introduce the MosaiQ® and LumiQ® platforms to the Moroccan market. These innovative solutions align with our vision to provide laboratories with best-in-class technologies that support improved diagnostic performance and patient outcomes,” said Mr. Fouad Bouchta, Chief Executive Officer, Reacting Sarl.
Visit our websites to learn more:
